Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change

Changes to customs procedures could affect some pathways used by Americans to obtain lower-cost prescription medications. The industry experts at SHARx, a supply-chain and procurement management company, are advocating to ensure those in need of...

Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma

Zifo, a global enabler of AI and data-driven enterprise informatics for science-driven organizations, unveiled its vision for an AI-driven scientific semantic layer, a dynamic framework designed to help Biopharma companies build a more trusted...

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the appointment of Peter Olagunju as Chief Executive Officer. Olagunju joins...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

Tsingke announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed proteins and antibodies. Combining gene synthesis, parallel expression, high-throughput...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

Tsingke announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed proteins and antibodies. Combining gene synthesis, parallel expression, high-throughput...

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

LEVEL, a science-driven cannabinoid company, announced results from an independent 29-day real-world study of its Relief Protab, conducted in partnership with third-party research firm MoreBetter. Across 427 adults with ongoing aches and pain, the...

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label for WINREVAIR™ (sotatercept-csrk) for injection, 45mg, 60mg, based on the Phase 3...

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

With nearly one in ten workplace fatalities now linked to drug overdoses, Padagis®, a leading provider of affordable generic pharmaceuticals, announced a new workplace preparedness initiative to expand access to naloxone in workplaces nationwide,...

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

StimCardio Medical announced positive results from the randomized, double-blind, sham-controlled NeuroPulse pilot study evaluating non-invasive median nerve stimulation (MNS) following atrial fibrillation (AF) ablation. The study was selected for...

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Bruker Corporation announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to...

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

Scitara, the Lab Connectivity and AI platform company serving the life sciences and biopharma industries, announced a new strategic direction for the company alongside the appointment of Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer. The...

Stasis Introduces the First Day-and-Night Supplement System Built for Children Who Take Stimulants

Stasis, the company behind the first supplement system designed to be taken alongside stimulants, today introduced Stasis Kids, a day-and-night nutritional supplement system made for children ages 6 to 17. In 2023, 16.5 million people in the...

Chemify Becomes the First Chemistry Hyperscaler with £22 Million in Grants from Scottish Enterprise and the UK Government

Chemify, the deep-tech pioneer of Chemputation, an end-to-end approach combining AI with robotic synthesis for molecular and materials discovery, has received £22 million ($29.7 million) in grants from Scottish Enterprise and the UK Government....

Lundbeck Receives Marketing Authorization for Vyepti® (eptinezumab) in Japan for the Prevention of Migraine Attacks

H. Lundbeck A/S announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has granted marketing authorization for eptinezumab for the prevention of migraine attacks in adults, marking an important milestone for patients in Japan...

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish a Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

AptarGroup, Inc. a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General...

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

Asahi Kasei Bioprocess, a subsidiary of diversified global company Asahi Kasei, will unveil the VANTIJ® SU-VFC Benchtop at Bioprocess International East (BPI EAST) 2026. This new VANTIJ® SU-VFC is a small-format system designed to deliver...

PHC Launched MTR-OPC1-PW Interface Board in September to Strengthen Data Linkage Between Equipment and Customer Systems

PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; Head Office: Chiyoda-ku, Tokyo; President: Shinro Nakamura; hereinafter referred to as "PHC") Life Science Division Biomedica Business Group (PHCbi) is pleased to announce that the MTR-OPC-OPC1-PW,...

Avenacy Launched Cyclophosphamide for Injection, USP in the U.S. Market

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Cyclophosphamide for Injection, USP in the United States as a therapeutic generic equivalent for Cytoxan® as approved by...

5th MENA Congress for Rare Diseases 2026

5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel, Abu Dhabi, United Arab Emirates. 5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel,...

New HCPCS Billing Code Enables Medicare Reimbursement for Lasix® ONYU When Furnished Incident to a Physician’s Service

SQ Innovation announced that the Centers for Medicare & Medicaid Services (CMS) has established a new Healthcare Common Procedure Coding System (HCPCS) Level II code, J1946 ("Injection, furosemide (Lasix ONYU), 1 mg"), for its product Lasix® ONYU...